Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,535 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice.
Pandey B, Wang Z, Jimenez A, Bhatia E, Jain R, Beach A, Maniar D, Hosten J, O'Farrell L, Vantucci C, Hur D, Noel R, Ringuist R, Smith C, Ochoa MA, Roy K. Pandey B, et al. Among authors: jain r. bioRxiv [Preprint]. 2023 May 8:2023.05.05.539395. doi: 10.1101/2023.05.05.539395. bioRxiv. 2023. PMID: 37215018 Free PMC article. Preprint.
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine.
Atalis A, Keenum MC, Pandey B, Beach A, Pradhan P, Vantucci C, Jain R, Hosten J, Smith C, Kramer L, Jimenez A, Ochoa MA, Frey D, Roy K. Atalis A, et al. Among authors: jain r. bioRxiv [Preprint]. 2022 Feb 2:2022.01.31.478507. doi: 10.1101/2022.01.31.478507. bioRxiv. 2022. Update in: J Control Release. 2022 Jul;347:476-488. doi: 10.1016/j.jconrel.2022.05.023. PMID: 35132413 Free PMC article. Updated. Preprint.
A Dual-Adjuvanted Parenteral-Intranasal Subunit Nanovaccine generates Robust Systemic and Mucosal Immunity Against SARS-CoV-2 in Mice.
Pandey B, Wang Z, Jimenez A, Bhatia E, Jain R, Beach A, Maniar D, Hosten J, O'Farrell L, Vantucci C, Hur D, Noel R, Rinqguist R, Smith C, Ochoa MA, Roy K. Pandey B, et al. Among authors: jain r. Adv Sci (Weinh). 2024 Oct 1:e2402792. doi: 10.1002/advs.202402792. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 39352717
Machine learning approach for detection of MACE events within clinical trial data.
Spanias JA, Buderi R, Bourlon PL, Tso C, Strait C, Saunders D, Ports K, Chen W, Jain R, Koduru B, Gerome D, Yang E, Saltzmann S, Talwai A, Jain T, Aptekar J. Spanias JA, et al. Among authors: jain r. J Biopharm Stat. 2024 Nov 16:1-16. doi: 10.1080/10543406.2024.2420640. Online ahead of print. J Biopharm Stat. 2024. PMID: 39550609
GLP-1 receptor agonists for the treatment of obstructive sleep apnea and obesity.
Romariz L, Araújo B, Barbosa LM, Jain R, Porto Silva Janovsky CC; Obesity Study Group. Romariz L, et al. Among authors: jain r. Eur J Intern Med. 2024 Nov 15:S0953-6205(24)00445-X. doi: 10.1016/j.ejim.2024.10.027. Online ahead of print. Eur J Intern Med. 2024. PMID: 39550278 No abstract available.
The User's Guide to the Pharmacologic Glycemic Management of Type 2 Diabetes in Adults---2024 Update.
Diabetes Canada Clinical Practice Guidelines Expert Working Group; Butalia S, Bajaj HS, Jain R, Leung K, Mansell K, Reichert SM, Senior P, Shah BR. Diabetes Canada Clinical Practice Guidelines Expert Working Group, et al. Among authors: jain r. Can J Diabetes. 2024 Oct;48(7):425-430. doi: 10.1016/j.jcjd.2024.08.003. Can J Diabetes. 2024. PMID: 39550177 No abstract available.
Pharmacologic Glycemic Management of Type 2 Diabetes in Adults---2024 Update.
Diabetes Canada Clinical Practice Guidelines Expert Working Group; Shah BR, Bajaj HS, Butalia S, Dasgupta K, Eurich DT, Jain R, Leung K, Mansell K, Simpson S. Diabetes Canada Clinical Practice Guidelines Expert Working Group, et al. Among authors: jain r. Can J Diabetes. 2024 Oct;48(7):415-424. doi: 10.1016/j.jcjd.2024.08.002. Can J Diabetes. 2024. PMID: 39550176 No abstract available.
5,535 results